Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer

Triple–negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer with a poor response rate to conventional systemic treatment and high relapse rates. Members of the natural killer group 2D ligand (NKG2DL) family are expressed on cancer cells but are typically absent from he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:International Journal of Molecular Sciences
Main Authors: Polina Kaidun, Samuel J. Holzmayer, Sarah M. Greiner, Anna Seller, Christian M. Tegeler, Ilona Hagelstein, Jonas Mauermann, Tobias Engler, André Koch, Andreas D. Hartkopf, Helmut R. Salih, Melanie Märklin
Formato: Artigo
Publicado em: MDPI AG 2023-08-01
Assuntos:
NKG2D
Bispecific
Fusion protein
TNBC
Breast cancer
NK cell
Acesso em linha:https://www.mdpi.com/1422-0067/24/17/13156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://www.mdpi.com/1422-0067/24/17/13156

Registos relacionados